Origen de la red de primer grado Ryan Crisman.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Umoja Biopharma, Inc. engages in the development of immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. It offers an integrated cellular immunotherapy platform comprising VivoVec in vivo delivery, RACR/CAR synthetic receptor payload and TumorTag targeting technologies that attack cancer cells. The company was founded by Michael Jensen, Philip Low, Andy Scharenberg and Ryan Crisman and is headquartered in Seattle, WA.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ryan Crisman a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | President | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
W WORL | Pharmaceuticals: Major | Corporate Officer/Principal | |
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | Director/Board Member | |
PORTAGE BIOTECH INC. | Biotechnology | Director/Board Member | |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
Bayer Pharmaceuticals Corp. | President | ||
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | Medical Specialties | Director/Board Member | |
HealthPrize Technologies LLC
HealthPrize Technologies LLC Packaged SoftwareTechnology Services HealthPrize Technologies LLC provides medication adherence solutions for patients. It offers digital platform that improves medication adherence via combination of education and rewards. The company was founded by Thomas Kottler, Katrina Firlik and James Jorasch in September 2009 and is headquartered in Norwalk, CT. | Packaged Software | Director/Board Member | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BLUEBIRD BIO, INC. | Biotechnology | Consultant / Advisor | |
Concordia College (New York) | College/University | Undergraduate Degree | |
Long Island University | College/University | Graduate Degree | |
University of Bristol | College/University | Undergraduate Degree | |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Undergraduate Degree | |
The Rockefeller University | College/University | Corporate Officer/Principal | |
Credit Suisse Securities (USA) LLC
Credit Suisse Securities (USA) LLC Regional BanksFinance Credit Suisse Securities (USA) LLC provides a variety of capital raising, market making, advisory and brokerage services for governments, financial institutions, high-net-worth individuals, and corporate clients and affiliates. It is also a primary dealer in U.S. government securities and an underwriter, placement agent, and dealer for money market instruments, commercial paper, mortgage and other assetbacked securities, as well as a range of debt, equity and other convertible securities of corporations and other issuers. The company was founded on January 3, 2003 and is headquartered in New York, NY. | Regional Banks | Director/Board Member | |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
Lederle International | Corporate Officer/Principal | ||
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Harvard Medical School | College/University | Doctorate Degree | |
DCVC Management Co. LLC
DCVC Management Co. LLC Investment ManagersFinance DCVC Management Co LLC (DCVC) is a venture capital firm founded in 2011 by Zachary Bogue and Matthew Ocko. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Nidus Investment Partners LP
Nidus Investment Partners LP Investment ManagersFinance Nidus Investment Partners LP (Nidus Investment Partners) a venture capital firm founded in 2010 by Vicki A. Gonzalez, Duke Leahey and Mich B. Hein. The firm is headquartered in St. Louis, Missouri. | Investment Managers | Director/Board Member | |
Harvard College | College/University | Undergraduate Degree | |
UNC School of Medicine | College/University | Graduate Degree | |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Atomwise, Inc.
Atomwise, Inc. Medical DistributorsDistribution Services Atomwise, Inc. develops artificial intelligence systems. It specializes in drug discovery and machine learning. The company was founded by Abraham Heifets, Izhar Wallach and Alexander Levy and is headquartered in Wilmington, DE. | Medical Distributors | Director/Board Member | |
REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member | |
PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member | |
GENERATION BIO CO. | Pharmaceuticals: Major | Founder | |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | ||
BioPhero ApS
BioPhero ApS Miscellaneous Commercial ServicesCommercial Services BioPhero ApS provides bio-based pheromones for pest management. The company was founded by Irina Borodina and Carina Holkenbrink and is headquartered in Kongens Lyngby, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Pharmaceuticals: Major | Director/Board Member | |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Pharmaceuticals: Major | Director/Board Member | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Paros Bio, Inc.
Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a private company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. The company is focused on developing a gene replacement approach to treat autosomal dominant Alzheimer's disease (ADAD). Specifically, they are working on a gene therapy that targets mutations in the presenilin 1 gene (PSEN1), which is the underlying genetic cause of ADAD. | Biotechnology | Director/Board Member | |
JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director/Board Member | |
Auron Therapeutics, Inc.
Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auron Therapeutics, Inc. operates as a biotechnology company. It aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. The company was founded by Kate Yen, Matt Vander Heiden, Ross Levine, and Eytan Stein and is headquartered in Wellesley, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Jasper Tx Corp.
Jasper Tx Corp. BiotechnologyHealth Technology Jasper Tx Corp. operates as a biotechnology company. It engages in the clinical development of novel therapies. The company was founded by Susan S. Prohaska and Judith Shizuru and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 41 |
Alemania | 3 |
Japón | 2 |
Reino Unido | 2 |
Países Bajos | 2 |
Sectorial
Health Technology | 24 |
Consumer Services | 10 |
Finance | 9 |
Commercial Services | 4 |
Technology Services | 2 |
Operativa
Director/Board Member | 81 |
Corporate Officer/Principal | 22 |
Chairman | 18 |
Independent Dir/Board Member | 18 |
Private Equity Investor | 13 |
Las relaciones más conectadas
Insiders | |
---|---|
Luke Evnin | 42 |
Dieter Weinand | 32 |
John Hamer | 24 |
Robert Glassman | 16 |
Gregory Sargen | 15 |
Anna Phil | 10 |
Andrew Scharenberg | 7 |
Mike Fitzpatrick | 3 |
- Bolsa de valores
- Insiders
- Ryan Crisman
- Conexiones Empresas